Synthetic biology based construction of biological activity-related library of fungal decalin-containing diterpenoid pyrones.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
14 04 2020
Historique:
received: 18 10 2019
accepted: 19 03 2020
entrez: 15 4 2020
pubmed: 15 4 2020
medline: 22 7 2020
Statut: epublish

Résumé

A synthetic biology method based on heterologous biosynthesis coupled with genome mining is a promising approach for increasing the opportunities to rationally access natural product with novel structures and biological activities through total biosynthesis and combinatorial biosynthesis. Here, we demonstrate the advantage of the synthetic biology method to explore biological activity-related chemical space through the comprehensive heterologous biosynthesis of fungal decalin-containing diterpenoid pyrones (DDPs). Genome mining reveals putative DDP biosynthetic gene clusters distributed in five fungal genera. In addition, we design extended DDP pathways by combinatorial biosynthesis. In total, ten DDP pathways, including five native pathways, four extended pathways and one shunt pathway, are heterologously reconstituted in a genetically tractable heterologous host, Aspergillus oryzae, resulting in the production of 22 DDPs, including 15 new analogues. We also demonstrate the advantage of expanding the diversity of DDPs to probe various bioactive molecules through a wide range of biological evaluations.

Identifiants

pubmed: 32286350
doi: 10.1038/s41467-020-15664-4
pii: 10.1038/s41467-020-15664-4
pmc: PMC7156458
doi:

Substances chimiques

Amyloid beta-Peptides 0
Anti-HIV Agents 0
Diterpenes 0
Naphthalenes 0
Protein Aggregates 0
Pyrones 0
decalin 88451Q4XYF

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1830

Références

Koehn, F. E. & Carter, G. T. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov. 4, 206–220 (2005).
pubmed: 15729362 doi: 10.1038/nrd1657
Newman, D. J. & Cragg, G. M. Natural products as source of new drugs from 1981 to 2014. J. Nat. Prod. 79, 629–661 (2016).
pubmed: 26852623 doi: 10.1021/acs.jnatprod.5b01055
Matsuda, Y. & Abe, I. Biosynthesis of fungal meroterpenoids. Nat. Prod. Rep. 33, 26–53 (2016).
pubmed: 26497360 doi: 10.1039/C5NP00090D
Masschelein, J., Jenner, M. & Challis, G. L. Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights. Nat. Prod. Rep. 34, 712–783 (2017).
pubmed: 28650032 doi: 10.1039/C7NP00010C
Kellenberger, E., Hofmann, A. & Quinn, R. J. Similar interactions of natural products with biosynthetic enzymes and therapeutic targets could explain why nature produces such a large proportion of existing drugs. Nat. Prod. Rep. 28, 1483–1492 (2011).
pubmed: 21779594 doi: 10.1039/c1np00026h
Rosén, J., Gottfries, J., Muresan, S., Backlund, A. & Oprea, T. I. Novel chemical space exploration via natural products. J. Med. Chem. 52, 1953–1962 (2009).
pubmed: 19265440 pmcid: 2696019 doi: 10.1021/jm801514w
Clardy, J. & Walsh, C. Lessons from natural molecules. Nature 432, 829–837 (2004).
pubmed: 15602548 doi: 10.1038/nature03194
Over, B. et al. Natural-product-derived fragments for fragment-based ligand discovery. Nat. Chem. 5, 21–28 (2013).
pubmed: 23247173 doi: 10.1038/nchem.1506
Maier, M. E. Design and synthesis of analogues of natural products. Org. Biomol. Chem. 13, 5302–5343 (2015).
pubmed: 25829247 doi: 10.1039/C5OB00169B
Robles, O. & Romo, D. Chemo- and site-selective derivatizations of natural products enabling biological studies. Nat. Prod. Rep. 31, 318–334 (2014).
pubmed: 24468713 pmcid: 4041598 doi: 10.1039/C3NP70087A
Harvey, A. L., Edrada-Ebel, R. & Quinn, R. J. The re-emergence of natural products for drug discovery in the genomics era. Nat. Rev. Drug Discov. 14, 111–129 (2015).
pubmed: 25614221 doi: 10.1038/nrd4510
Jørgensen, L. et al. 14-step synthesis of (+)-ingenol from (+)-3-carene. Science 341, 878–882 (2013).
pubmed: 23907534 doi: 10.1126/science.1241606
Kuroda, Y. et al. Isolation, synthesis and bioactivity studies of phomactin terpenoids. Nat. Chem. 10, 938–945 (2018).
pubmed: 30061613 doi: 10.1038/s41557-018-0084-x
Llabani, E. et al. Diverse compounds from pleuromutilin lead to a thioredoxin inhibitor and inducer of ferroptosis. Nat. Chem. 11, 521–532 (2019).
pubmed: 31086302 pmcid: 6639018 doi: 10.1038/s41557-019-0261-6
Balthaser, B. R., Maloney, M. C., Beeler, A. B., Porco, J. A. & Snyder, J. K. Remodeling of the natural product fumagillol employing a reaction discovery approach. Nat. Chem. 3, 969–973 (2011).
pubmed: 22213919 pmcid: 3254213 doi: 10.1038/nchem.1178
Huigens, R. W. et al. A ring-distortion strategy to construct stereochemically complex and structurally diverse compounds from natural products. Nat. Chem. 5, 195–202 (2013).
pubmed: 23422561 pmcid: 3965367 doi: 10.1038/nchem.1549
Asai, T. et al. Use of a biosynthetic intermediate to explore the chemical diversity of pseudo-natural fungal polyketides. Nat. Chem. 7, 737–743 (2015).
Keller, N. P., Turner, G. & Bennett, J. W. Fungal secondary metabolism from biochemistry to genomics. Nat. Rev. Microbiol. 3, 937–947 (2005).
pubmed: 16322742 doi: 10.1038/nrmicro1286
Sanchez, J. F., Somoza, A. D., Keller, N. P. & Wang, C. C. C. Advances in Aspergillus secondary metabolite research in the post-genomic era. Nat. Prod. Rep. 29, 351–371 (2012).
pubmed: 22228366 pmcid: 4568942 doi: 10.1039/c2np00084a
Hertweck, C. Hidden biosynthetic treasures brought to light. Nat. Chem. Biol. 5, 450–452 (2009).
pubmed: 19536102 doi: 10.1038/nchembio0709-450
Li, L. et al. Genome mining and assembly-line biosynthesis of the UCS1025A pyrrolizidinone family of fungal alkaloids. J. Am. Chem. Soc. 140, 2067–2071 (2016).
doi: 10.1021/jacs.8b00056
Fujii, R. et al. H. Total biosynthesis of diterpene aphidicolin, a specific inhibitor of DNA polymerase α: heterologous expression of four biosynthetic genes in Aspergillus oryzae. Biosci. Biotechnol. Biochem. 75, 1813–1817 (2011).
pubmed: 21897020 doi: 10.1271/bbb.110366
Tagami, K. et al. Reconstitution of biosynthetic machinery for indole-diterpene paxilline in Aspergillus oryzae. J. Am. Chem. Soc. 135, 1260–1263 (2013).
pubmed: 23311903 doi: 10.1021/ja3116636
Matsuda, Y., Wakimoto, T., Mori, T., Awakawa, T. & Abe, I. Complete biosynthetic pathway of anditomin: nature’s sophisticated synthetic route to a complex fungal meroterpenoid. J. Am. Chem. Soc. 136, 15326–15336 (2014).
pubmed: 25216349 doi: 10.1021/ja508127q
Itoh, T. et al. Reconstitution of a fungal meroterpenoid biosynthesis reveals the involvement of a novel family of terpene cyclases. Nat. Chem. 2, 858–864 (2010).
pubmed: 20861902 doi: 10.1038/nchem.764
Morishita, Y., Zhang, H., Taniguchi, T., Mori, K. & Asai, T. The discovery of fungal polyene macrolides via a postgenomic approach reveals a polyketide macrocyclization by trans-acting thioesterase in fungi. Org. Lett. 21, 4788–4792 (2019).
pubmed: 31180682 doi: 10.1021/acs.orglett.9b01674
Kaneko, A., Morishita, Y., Tsukada, K., Taniguchi, T. & Asai, T. Genome-based discovery of alkylresorcinols from a cricket-associated fungus, Penicillium soppi, that displays an unusual polyketide biosynthetic machinery. Org. Biomol. Chem. 17, 5239–5243 (2019).
pubmed: 31086874 doi: 10.1039/C9OB00807A
Harvey, C. J. B. et al. HEx: a heterologous expression platform for the discovery of fungal natural products. Sci. Adv. 4, eaar5459 (2018).
pubmed: 29651464 pmcid: 5895447 doi: 10.1126/sciadv.aar5459
Liu, T., Chiang, Y. M., Somoza, A. D., Oakley, B. R. & Wang, C. C. C. Engineering of an “unnatural” natural product by swapping polyketide synthase domains in Aspergillus nidulans. J. Am. Chem. Soc. 133, 13314–13316 (2011).
pubmed: 21815681 pmcid: 3350771 doi: 10.1021/ja205780g
Xu, Y. et al. Diversity-oriented combinatorial biosynthesis of benzenediol lactone scaffolds by subunit shuffling of fungal polyketide synthases. Proc. Natl Acad. Sci. USA 111, 12354–12359 (2014).
pubmed: 25049383 doi: 10.1073/pnas.1406999111
Awakawa, T. et al. Reprogramming of the antimycin NRPS-PKS assembly lines inspired by gene evolution. Nat. Commun. 9, 3534 (2018).
pubmed: 30166552 pmcid: 6117356 doi: 10.1038/s41467-018-05877-z
Yan, F. et al. Synthetic biology approaches and combinatorial biosynthesis towards heterologous lipopeptide production. Chem. Sci. 9, 7510–7519 (2018).
pubmed: 30319751 pmcid: 6180311 doi: 10.1039/C8SC02046A
Gupta, S. et al. Viridoxins A and B: novel toxins from the fungus Metarhizium flavoviride. J. Org. Chem. 58, 1062–1067 (1993).
doi: 10.1021/jo00057a017
Engel, B., Erkel, G., Anke, T. & Sterner, O. Sesquicillin, an inhibitor of glucocorticoid mediated signal transduction. J. Antibiot. 51, 518–521 (1998).
Uchida, R. et al. New sesquicillins, insecticidal antibiotics produced by Albophoma sp. FKI-1778. J. Antibiot. 58, 397–404 (2005).
pubmed: 16156516 doi: 10.1038/ja.2005.50 pmcid: 16156516
Lai, K. et al. Integrated compound profiling screens identify the mitochondrial electron transport chain as the molecular target of the natural products manassantin, sesquicillin, and arctigenin. ACS Chem. Biol. 8, 257–267 (2013).
pubmed: 23138533 doi: 10.1021/cb300495e pmcid: 23138533
Kikuchi, H. et al. New diterpene pyrone-type compounds, metarhizins A and B, isolated from entomopathogenic fungus, Metarhizium flavoviride and their inhibitory effects on cellular proliferation. Tetrahedron 65, 469 (2009).
doi: 10.1016/j.tet.2008.11.014
Lee, J. C., Lobkovsky, E., Pliam, N. B., Strobel, G. & Clardy, J. Subglutinols A and B: immunosuppressive compounds from the endophytic fungus Fusarium subglutinans. J. Org. Chem. 60, 7076–7077 (1995).
doi: 10.1021/jo00127a001
Lee, W. G. et al. Immunosuppressive effects of subglutinol derivatives. ChemMedChem 7, 218–222 (2012).
pubmed: 22114006 doi: 10.1002/cmdc.201100409 pmcid: 22114006
Cimmino, A. et al. Higginsianins A and B, two diterpenoid α-pyrones produced by Colletotrichum higginsianum, with in vitro cytostatic activity. J. Nat. Prod. 79, 116–125 (2016).
pubmed: 26697898 doi: 10.1021/acs.jnatprod.5b00779
Gohbara, M. et al. Structures of colletotrichin and colletotrichin B, phytotoxic metabolites from Colletotrichum nicotianae. Agric. Biol. Chem. 42, 1037–1043 (1978).
Zhang, F. & Danishefsky, S. J. An efficient stereoselective total synthesis of DL-sesquicillin, a glucocorticoid antagonist. Angew. Chem. Int. Ed. 41, 1434–1437 (2002).
doi: 10.1002/1521-3773(20020415)41:8<1434::AID-ANIE1434>3.0.CO;2-A
Kim, H. et al. Stereoselective synthesis and osteogenic activity of subglutinols A and B. J. Am. Chem. Soc. 131, 3192–3194 (2009).
pubmed: 19216570 doi: 10.1021/ja8101192
Oguchi, T., Watanabe, K., Ohkubo, K., Abe, H. & Katou, T. Enantioselective total synthesis of (–)‐subglutinols A and B: potential immunosuppressive agents isolated from a microorganism. Chem. Eur. J. 15, 2826–2845 (2009).
pubmed: 19191240 doi: 10.1002/chem.200802122
Merchant, R. R. et al. Divergent synthesis of pyrone diterpenes via radical cross coupling. J. Am. Chem. Soc. 140, 7462–7465 (2018).
pubmed: 29921130 pmcid: 6016063 doi: 10.1021/jacs.8b04891
Kato, H. et al. New natural products isolated from Metarhizium robertsii ARSEF 23 by chemical screening and identification of the gene cluster through engineered biosynthesis in Aspergillus nidulans A1145. J. Antibiot. 69, 561–566 (2016).
pubmed: 27189118 doi: 10.1038/ja.2016.54
Jin, F. J., Maruyama, J., Juvvadi, P. R., Arioka, M. & Kitamoto, K. Development of a novel quadruple auxotrophic host transformation system by argB gene disruption using adeA gene and exploiting adenine auxotrophy in Aspergillus oryzae. FEMS Microbiol. Lett. 239, 79–85 (2004).
pubmed: 15451104 doi: 10.1016/j.femsle.2004.08.025
Matsuda, Y., Awakawa, T. & Abe, I. Reconstituted biosynthesis of fungal meroterpenoid andrastin A. Tetrahedron 69, 8199–8204 (2013).
doi: 10.1016/j.tet.2013.07.029
Ohtani, I., Kusumi, T., Kashman, Y. & Kakisawa, H. High-field FT NMR application of Mosher’s method. The absolute configurations of marine terpenoids. J. Am. Chem. Soc. 113, 4092–4096 (1991).
doi: 10.1021/ja00011a006
Dan, S. et al. An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines. Cancer Res. 62, 1139–1147 (2002).
pubmed: 11861395
Kitamura, K., Itoh, H., Ssakurai, K., Dan, S. & Inoue, M. Target Identification of Yaku’amide B and its two distinct activities against mitochondrial F0F1-ATP synthase. J. Am. Chem. Soc. 140, 12189–12199 (2018).
pubmed: 30156840 doi: 10.1021/jacs.8b07339
Lytle, N. K., Barber, A. G. & Reya, T. Stem cell fate in cancer growth, progression and therapy resistance. Nat. Rev. Cancer 18, 669–680 (2018).
pubmed: 30228301 doi: 10.1038/s41568-018-0056-x
Bai, X., Ni, J., Beretov, J., Graham, P. & Li, Y. Cancer stem cell in breast cancer therapeutic resistance. Cancer Treat. Rev. 69, 152–163 (2018).
pubmed: 30029203 doi: 10.1016/j.ctrv.2018.07.004
Park, J. H., Chung, S., Matsuo, Y. & Nakamura, Y. Development of small molecular compounds targeting cancer stem cells. Medchemcomm 8, 73–80 (2016).
pubmed: 30108692 pmcid: 6072478 doi: 10.1039/C6MD00385K
Hirata, N. et al. Sphingosine-1-phosphate promotes expansion of cancer stem cells via S1PR3 by a ligand-independent Notch activation. Nat. Commun. 5, 4806 (2014).
pubmed: 25254944 doi: 10.1038/ncomms5806
Chen, J. et al. Inhibition of cancer stem cell like cells by a synthetic retinoid. Nat. Commun. 9, 1406 (2018).
pubmed: 29643385 pmcid: 5895803 doi: 10.1038/s41467-018-03877-7
Lemaitre, B. & Hoffmann, J. The host defense of Drosophila melanogaster. Annu. Rev. Immunol. 25, 697–743 (2007).
pubmed: 17201680 doi: 10.1146/annurev.immunol.25.022106.141615
Kanoh, H. et al. Genome-wide RNAi screening implicates the E3 ubiquitin ligase Sherpa in mediating innate immune signaling by Toll in Drosophila adults. Sci. Signal. 8, ra107 (2015).
Manaka, J. et al. Draper-mediated and phosphatidylserine-independent phagocytosis of apoptotic cells by Drosophila Hemocytes/Macrophages. J. Biol. Chem. 279, 48466–48476 (2004).
pubmed: 15342648 doi: 10.1074/jbc.M408597200
Nonaka, S. et al. Characterization of Spz5 as a novel ligand for Drosophila Toll-1 receptor. Biochem. Biophys. Res. Commun. 506, 510–515 (2018).
pubmed: 30361090 doi: 10.1016/j.bbrc.2018.10.096 pmcid: 30361090
Kanoh, H. et al. Ex vivo genome-wide RNAi screening of the Drosophila Toll signaling pathway elicited by a larva-derived tissue extract. Biochem. Biophys. Res. Commun. 467, 400–406 (2015).
pubmed: 26427875 doi: 10.1016/j.bbrc.2015.09.138
Kajiwara, K., Kodama, E. & Matsuoka, M. A novel colorimetric assay for CXCR4 and CCR5 tropic human immunodeficiency viruses. Antivir. Chem. Chemother. 17, 215–223 (2006).
pubmed: 17066899 doi: 10.1177/095632020601700405
Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 101–112 (2007).
pubmed: 17245412 doi: 10.1038/nrm2101
Hasegawa, K., Yamaguchi, I., Omata, S., Gejyo, F. & Naiki, H. Interaction between A beta(1-42) and A beta(1-40) in Alzheimer’s beta-amyloid fibril formation in vitro. Biochemistry 38, 15514–15521 (1999).
pubmed: 10569934 doi: 10.1021/bi991161m
Serio, T. R. et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289, 1317–1321 (2000).
pubmed: 10958771 doi: 10.1126/science.289.5483.1317
Murakami, K. et al. Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions and 23. ACS Chem. Neurosci. 17, 747–756 (2010).
doi: 10.1021/cn100072e
Hanaki, M. et al. Mechanistic analyses of the suppression of amyloid β42 aggregation by apomorphine. Bioorg. Med. Chem. 26, 1538–1546 (2018).
pubmed: 29429575 doi: 10.1016/j.bmc.2018.01.028
Shen, B. A new golden age of natural products drug discovery. Cell 163, 1297–1300 (2015).
pubmed: 26638061 pmcid: 5070666 doi: 10.1016/j.cell.2015.11.031
Morishita, Y. et al. Use of plant hormones to activate silent polyketide biosynthetic pathways in Arthrinium sacchari, a fungus isolated from a spider. Org. Biomol. Chem. 17, 780–784 (2019).
pubmed: 30608107 doi: 10.1039/C8OB02837K

Auteurs

Kento Tsukada (K)

Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Komaba, Meguro-ku, Tokyo, 153-8902, Japan.

Shono Shinki (S)

Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Komaba, Meguro-ku, Tokyo, 153-8902, Japan.

Akiho Kaneko (A)

Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Komaba, Meguro-ku, Tokyo, 153-8902, Japan.

Kazuma Murakami (K)

Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.

Kazuhiro Irie (K)

Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.

Masatoshi Murai (M)

Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.

Hideto Miyoshi (H)

Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.

Shingo Dan (S)

Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Kumi Kawaji (K)

Department of Infectious Diseases, International Research Institute of Disaster Science, Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryocho, Aoba-ku, Sendai, 980-0875, Japan.

Hironori Hayashi (H)

Department of Intelligent Network for Infection Control, Graduate School of Medicine, Tohoku University, 2-1, Seiryocho, Aoba-ku, Sendai, 980-0875, Japan.

Eiichi N Kodama (EN)

Department of Infectious Diseases, International Research Institute of Disaster Science, Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryocho, Aoba-ku, Sendai, 980-0875, Japan.
Department of Intelligent Network for Infection Control, Graduate School of Medicine, Tohoku University, 2-1, Seiryocho, Aoba-ku, Sendai, 980-0875, Japan.

Aki Hori (A)

Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.

Emil Salim (E)

Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.

Takayuki Kuraishi (T)

Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.

Naoya Hirata (N)

Division of Pharmacology, National Institute of Health Sciences, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan.

Yasunari Kanda (Y)

Division of Pharmacology, National Institute of Health Sciences, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan.

Teigo Asai (T)

Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Komaba, Meguro-ku, Tokyo, 153-8902, Japan. teigo.asai.c8@tohoku.ac.jp.
Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-yama, Aoba-ku, Sendai, 980-8578, Japan. teigo.asai.c8@tohoku.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH